Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Guenther

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Molecular Genetics and Metabolism|April 11, 2025
Mechanistic insights into arimoclomol mediated effects on lysosomal function in Niemann-pick type C diseaseHadeel Shammas, Cathrine Kloster Fog, Pontus Klein, et al.
Current Medical Research and Opinion|May 16, 2022
Oral, intranasal, and intravenous abuse potential of serdexmethylphenidate, a novel prodrug of d-methylphenidateMegan J Shram, Beatrice Setnik, Lynn Webster, et al.
Vaccines|July 27, 2024
Clinical and Diagnostic Features of Post-Acute COVID-19 Vaccination Syndrome (PACVS)Anna Katharina Mundorf, Amelie Semmler, Harald Heidecke, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|August 19, 2024
The Antidepressant- and Anxiolytic-Like Effects of the Phosphodiesterase Type-5 Inhibitor Tadalafil are Associated with the Modulation of the Gut-Brain Axis During CNS AutoimmunityEduardo Duarte-Silva, Alice Chevrollier Oriá, Ingrid Prata Mendonça, et al.
Vaccines|November 25, 2023
Chronic Fatigue and Dysautonomia following COVID-19 Vaccination Is Distinguished from Normal Vaccination Response by Altered Blood MarkersAmelie Semmler, Anna Katharina Mundorf, Anna Sabrina Kuechler, et al.
Molecular Genetics and Metabolism|July 15, 2025
Long-term efficacy and safety of arimoclomol in Niemann-Pick disease type C: Final results of the phase 2/3 NPC-002 48-month open-label extension trialEugen Mengel, Rosalia M Da Riol, Mireia Del Toro, et al.
BMC Emergency Medicine|November 28, 2024
Prehospital telemedicine support for urban stroke care: Analysis of current state of care and conceptualizationDaniel Weiss, Christian Rubbert, Marius Kaschner, et al.
Molecular Genetics and Metabolism Reports|June 16, 2025
Efficacy results from a 12-month double-blind randomized trial of arimoclomol for treatment of Niemann-Pick disease type C (NPC): Presenting a rescored 4-domain NPC Clinical Severity ScaleEugen Mengel, Marc C Patterson, Rosalia M Da Riol, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Molecular Genetics and Metabolism|April 11, 2025
Mechanistic insights into arimoclomol mediated effects on lysosomal function in Niemann-pick type C diseaseHadeel Shammas, Cathrine Kloster Fog, Pontus Klein, et al.
Current Medical Research and Opinion|May 16, 2022
Oral, intranasal, and intravenous abuse potential of serdexmethylphenidate, a novel prodrug of d-methylphenidateMegan J Shram, Beatrice Setnik, Lynn Webster, et al.
Vaccines|July 27, 2024
Clinical and Diagnostic Features of Post-Acute COVID-19 Vaccination Syndrome (PACVS)Anna Katharina Mundorf, Amelie Semmler, Harald Heidecke, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|August 19, 2024
The Antidepressant- and Anxiolytic-Like Effects of the Phosphodiesterase Type-5 Inhibitor Tadalafil are Associated with the Modulation of the Gut-Brain Axis During CNS AutoimmunityEduardo Duarte-Silva, Alice Chevrollier Oriá, Ingrid Prata Mendonça, et al.
Vaccines|November 25, 2023
Chronic Fatigue and Dysautonomia following COVID-19 Vaccination Is Distinguished from Normal Vaccination Response by Altered Blood MarkersAmelie Semmler, Anna Katharina Mundorf, Anna Sabrina Kuechler, et al.
Molecular Genetics and Metabolism|July 15, 2025
Long-term efficacy and safety of arimoclomol in Niemann-Pick disease type C: Final results of the phase 2/3 NPC-002 48-month open-label extension trialEugen Mengel, Rosalia M Da Riol, Mireia Del Toro, et al.
BMC Emergency Medicine|November 28, 2024
Prehospital telemedicine support for urban stroke care: Analysis of current state of care and conceptualizationDaniel Weiss, Christian Rubbert, Marius Kaschner, et al.
Molecular Genetics and Metabolism Reports|June 16, 2025
Efficacy results from a 12-month double-blind randomized trial of arimoclomol for treatment of Niemann-Pick disease type C (NPC): Presenting a rescored 4-domain NPC Clinical Severity ScaleEugen Mengel, Marc C Patterson, Rosalia M Da Riol, et al.
Pageof 2